trending Market Intelligence /marketintelligence/en/news-insights/trending/yKB0fDH1dSeRrIAvQZWUbg2 content esgSubNav
In This List

Loxo Oncology director resigns

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Loxo Oncology director resigns

David Bonita resigned as a class II independent director of Loxo Oncology Inc., effective Dec. 22.

Bonita's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices.